Price Alert

Oncology Institute Inc. (TOI)

NASDAQ: TOI · Real-Time Price · USD

3.67

-0.43 (-10.49%)

At close: Aug 14, 2025, 3:59 PM

3.78

3.00%

Pre-market: Aug 15, 2025, 07:00 AM EDT

Oncology Institute Statistics

Share Statistics

Oncology Institute has 91.91M shares outstanding. The number of shares has increased by 21.76% in one year.

Shares Outstanding	91.91M
Shares Change (YoY)	21.76%
Shares Change (QoQ)	21.33%
Owned by Institutions (%)	2.19%
Shares Floating	45.43M
Failed to Deliver (FTD) Shares	55,270
FTD / Avg. Volume	2.56%

Short Selling Information

The latest short interest is 7.15M, so 7.77% of the outstanding shares have been sold short.

Short Interest	7.15M
Short % of Shares Out	7.77%
Short % of Float	9.52%
Short Ratio (days to cover)	3.21

Valuation Ratios

The PE ratio is -0.36 and the forward PE ratio is -23.97. Oncology Institute's PEG ratio is 0.02.

PE Ratio	-0.36
Forward PE	-23.97
PS Ratio	0.06
Forward PS	0.7
PB Ratio	6.46
P/FCF Ratio	-0.76
PEG Ratio	0.02

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Oncology Institute.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.15, with a Debt / Equity ratio of 34.31.

Current Ratio	2.15
Quick Ratio	1.96
Debt / Equity	34.31
Debt / EBITDA	-2.42
Debt / FCF	-4.06
Interest Coverage	-8.02

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$476.86K
Profits Per Employee	$-78.38K
Employee Count	825
Asset Turnover	2.28
Inventory Turnover	33.81

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by 774.23% in the last 52 weeks. The beta is 0.11, so Oncology Institute's price volatility has been higher than the market average.

Beta	0.11
52-Week Price Change	774.23%
50-Day Moving Average	3.04
200-Day Moving Average	1.54
Relative Strength Index (RSI)	73.07
Average Volume (20 Days)	2,160,996

Income Statement

In the last 12 months, Oncology Institute had revenue of 393.41M and earned -64.66M in profits. Earnings per share was -0.71.

Revenue	393.41M
Gross Profit	54M
Operating Income	-60.12M
Net Income	-64.66M
EBITDA	-50.88M
EBIT	-57.17M
Earnings Per Share (EPS)	-0.71

Full Income Statement

Balance Sheet

The company has 49.67M in cash and 123.15M in debt, giving a net cash position of -73.48M.

Cash & Cash Equivalents	49.67M
Total Debt	123.15M
Net Cash	-73.48M
Retained Earnings	-210.81M
Total Assets	164M
Working Capital	47.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -26.54M and capital expenditures -3.79M, giving a free cash flow of -30.33M.

Operating Cash Flow	-26.54M
Capital Expenditures	-3.79M
Free Cash Flow	-30.33M
FCF Per Share	-0.4

Full Cash Flow Statement

Margins

Gross margin is 13.73%, with operating and profit margins of -15.28% and -16.44%.

Gross Margin	13.73%
Operating Margin	-15.28%
Pretax Margin	-16.44%
Profit Margin	-16.44%
EBITDA Margin	-12.93%
EBIT Margin	-15.28%
FCF Margin	-7.71%

Dividends & Yields

TOI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for TOI is $6, which is 41.5% higher than the current price. The consensus rating is "Buy".

Price Target	$6
Price Target Difference	41.5%
Analyst Consensus	Buy
Analyst Count	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	1.25
Piotroski F-Score	4